"A-Share Focus" Staidson BioPharm plummets 8.5%, the third-largest shareholder plans to reduce holdings
I'm LongbridgeAI, I can summarize articles.Pharmaceutical company Staidson BioPharm (Shenzhen: 300204) saw its stock price plummet by 8.5%, currently reported at 34.02 yuan. The company announced that its third-largest shareholder, Xiangtang Group, plans to reduce its holdings by no more than 4.7777 million shares, accounting for 1% of the total share capital. Based on yesterday's closing price, the cash amount that Xiangtang Group will realize is approximately 178 million yuan. Xiangtang Group currently holds 27.1396 million shares, accounting for 5.68% of the total share capital. This year, Staidson's stock price has increased by 361%
According to a report from the Economic Information Agency on the 6th, pharmaceutical company Staidson BioPharm (Shenzhen: 300204) is currently down 8.5%, trading at 34.02 yuan (RMB). The company announced on the 5th that its third-largest shareholder, Xiangtang Group, plans to reduce its holdings by no more than 4.7777 million shares, accounting for 1% of the company's total share capital. Based on yesterday's closing price of 37.18 yuan, the cash amount that Xiangtang Group would realize is approximately 178 million yuan. As of now, Xiangtang Group holds 27.1396 million shares, accounting for 5.68% of the total share capital. Staidson BioPharm's stock price has already surged 361% this year. (ry)